Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study

by Dejan B. Budimirovic, Dejan B. Budimirovic, Kelli C. Dominick, Kelli C. Dominick, Lidia V. Gabis, Lidia V. Gabis, Maxwell Adams, Mathews Adera, Linda Huang, Pamela Ventola, Nicole R. Tartaglia, Elizabeth Berry-Kravis
Published 2021-10-01